Literature DB >> 17235051

Hand-foot and stump syndrome to sorafenib.

Susan E Lai1, Timothy Kuzel, Mario E Lacouture.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17235051     DOI： 10.1200/JCO.2006.08.9565

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

1.  Anticancer drug induced palmar plantar erythrodysesthesia.

Authors:  Muthiah Palaniappan; Sureshkumar Srinivasamurthy; Biswajit Dubashi; Adithan Chandrasekaran
Journal:  J Clin Diagn Res       Date:  2014-10-20

2.  Localized palmar-plantar epidermal hyperplasia associated with use of sorafenib.

Authors:  Demet Cicek; Basak Kandi; Ferda A Dagli; Aziz Karaoglu; Beyzan D Haligur
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

3.  Candidate mechanisms for capecitabine-related hand-foot syndrome.

Authors:  Gérard Milano; Marie-Christine Etienne-Grimaldi; Mireille Mari; Sandra Lassalle; Jean-Louis Formento; Mireille Francoual; Jean-Philippe Lacour; Paul Hofman
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

4.  Late presentation of sorafenib-associated rash: a case report.

Authors:  Thomas Sarkodie; Paul Ross
Journal:  J Med Case Rep       Date:  2010-10-25

5.  Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy.

Authors:  Nilofer S Azad; Jeanny B Aragon-Ching; William L Dahut; Martin Gutierrez; William D Figg; Lokesh Jain; Seth M Steinberg; Maria L Turner; Elise C Kohn; Heidi H Kong
Journal:  Clin Cancer Res       Date:  2009-02-15       Impact factor: 12.531

6.  Sorafenib-induced hand-foot skin reaction: a Koebner phenomenon?

Authors:  V Sibaud; J P Delord; C Chevreau
Journal:  Target Oncol       Date:  2009-11-07       Impact factor: 4.493

Review 7.  Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management.

Authors:  B McLellan; F Ciardiello; M E Lacouture; S Segaert; E Van Cutsem
Journal:  Ann Oncol       Date:  2015-06-01       Impact factor: 32.976

8.  Side effects of Sorafenib and sunitinib: A new concern for dermatologist and oncologist.

Authors:  Prachi Gole; Bhushan Madke; Uday Khopkar; Prabhash Kumar; Vanita Noronha; Monali Yadav
Journal:  Indian Dermatol Online J       Date:  2014-01

9.  Sorafenib Induced Hand Foot Skin Rash in FLT3 ITD Mutated Acute Myeloid Leukemia-A Case Report and Review of Literature.

Authors:  Jayastu Senapati; Anup J Devasia; Abhijeet Ganapule; Leni George; Auro Viswabandya
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-02-17       Impact factor: 2.576

10.  Sorafenib induced acral pigmentation: A new entity.

Authors:  Mrinal Gupta; Heena Gupta; Anish Gupta
Journal:  Avicenna J Med       Date:  2015 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.